News
12-16-2010, 12:30 PM
U.S. Food and Drug Administration officials have recommended revoking approval of the medication Avastin (bevacizumab) for the treatment of breast cancer.
More... (http://www.healthcentral.com/breast-cancer/news-559744-98.html)
More... (http://www.healthcentral.com/breast-cancer/news-559744-98.html)